Natco Pharma: Focusing On Complex Products

Despite reporting stellar net profits in Q1 & Q2, they chose to maintain the FY guidelines of 1000-1200 Cr. Also said Q3 will be a little weak (Q3 FY23 net profit was merely 57 Cr) with Q4 likely to be better. Cause for concern?